Pendent Chain Functionalized Polyacetals That Display pH-Dependent Degradation: A Platform for the Development of Novel Polymer Therapeutics
The DOI matches its Crossref record.
Abstract
The synthetic polymers that are used to prepare polymer therapeutics reaching clinical use are predominantly nonbiodegradable, and this severely limits the molecular weight range that will give certainty of safe elimination. The aim of this study was to synthesize water-soluble, biocompatible, amino-functionalized polyacetals that would display pH-dependent degradation and, moreover, be suitable for drug conjugation. To test the feasibility of the synthetic procedure, polyacetals were first prepared by the reaction of a diol (e.g., poly(ethylene glycol) (PEG)) and a divinyl ether (e.g., tri(ethylene glycol) divinyl ether) using an acid catalyst. Using PEG 3400, these polyacetals had a M w of 36 000−43 000 g/mol ( M w / M n = 1.6−1.8) and displayed pH-dependent degradation. An enhanced rate of hydrolysis was seen at pH 5.5 (41% M w loss in 25 h) compared to pH 7.4 (10% M w loss in 73 h). The polymers and their degradation products were nontoxic toward B16F10 cells in vitro (IC 50 > 5 mg/mL), and they were also nonhemolytic (rat red blood cells). Several approaches were examined to produce amino-functionalized polyacetals. It was found that modification of either the divinyl ether or PEG monomer was not the best strategy. However, terpolymerization, for example using the hydrolytically stable diol 9-fluorenylmethyloxycarbonyl (Fmoc)-serinol, PEG 3400, and tri(ethylene glycol) divinyl ether, did produce functionalized polyacetals of M w 20 000−77 000 g/mol and M w / M n = 1.8−2.0. Varying the ratios of diol monomer gave a family of polymers containing different amounts of pendent group. One of these amino-polyacetals was used to prepare a polymer containing 125 I-labeled Bolton−Hunter reagent (74 μCi/mg), introduced to facilitate a preliminary biodistribution study after intravenous administration to rats. The polyacetals showed no preferential accumulation in the major organs (at 1 h; liver (4.2 % dose), lung (0.7%), and kidney (1.1%)), and the log blood clearance with time was linear over 24 h. These novel, biodegradable polyacetals have potential for further development as polymer therapeutics and more generally as a new family of biodegradable polymers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
The dawning era of polymer therapeutics
Duncan, R. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1088 · Cited by 3,269
Self-citationKamaly, N., Yameen, B., Wu, J., & Farokhzad, O. C. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00346 · Cited by 3,070
Ulbrich, K., Holá, K., Šubr, V., Bakandritsos, A., Tuček, J., & Zbořil, R. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00589 · Cited by 1,730
Nanostructured materials for applications in drug delivery and tissue engineering
Goldberg, M., Langer, R., & Jia, X. (2007) · Journal of Biomaterials Science, Polymer Edition · doi:10.1163/156856207779996931 · Cited by 1,054
Lifetime prediction of biodegradable polymers
Laycock, B., Nikolić, M., Colwell, J. M., Gauthier, E., Halley, P., Bottle, S., & George, G. (2017) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2017.02.004 · Cited by 662
Polymeric anticancer drugs with pH-controlled activation
Ulbrich, K. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.10.040 · Cited by 494
Prodrug Strategies in Anticancer Chemotherapy
Kratz, F., Müller, I. A., Ryppa, C., & Warnecke, A. (2008) · ChemMedChem · doi:10.1002/cmdc.200700159 · Cited by 486
Design and development of polymeric micelles with cleavable links for intracellular drug delivery
Wei, H., Zhuo, R.-X., & Zhang, X.-Z. (2013) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2012.07.002 · Cited by 474
Polymer conjugates: nanosized medicines for treating cancer
Vicent, M. J., & Duncan, R. (2006) · Trends in Biotechnology · doi:10.1016/j.tibtech.2005.11.006 · Cited by 443
Self-citationAcid-degradable polymers for drug delivery: a decade of innovation
Binauld, S., & Stenzel, M. H. (2013) · Chemical Communications · doi:10.1039/c2cc36589h · Cited by 421
Dendrimers: a new class of nanoscopic containers and delivery devices
Aulenta, F., Hayes, W., & Rannard, S. (2003) · European Polymer Journal · doi:10.1016/s0014-3057(03)00100-9 · Cited by 400
Anticancer Polymeric Nanomedicines
Tong, R., & Cheng, J. (2007) · Polymer Reviews · doi:10.1080/15583720701455079 · Cited by 310
Nanoescapology: progress toward understanding the endosomal escape of polymeric nanoparticles
Selby, L. I., Cortez‐Jugo, C. M., Such, G. K., & Johnston, A. P. R. (2017) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1452 · Cited by 283
Biodegradable, polymeric nanoparticle delivery systems for cancer therapy
Pridgen, E. M., Langer, R., & Farokhzad, O. C. (2007) · Nanomedicine · doi:10.2217/17435889.2.5.669 · Cited by 249
Polymeric micelles: authoritative aspects for drug delivery
Kulthe, S. S., Choudhari, Y. M., Inamdar, N. N., & Mourya, V. (2012) · Designed Monomers and Polymers · doi:10.1080/1385772x.2012.688328 · Cited by 235
“Accordingly, a pentablock copolymer was synthesized by the coupling of pHsensitive poly(β-amino ester) to thermosensitive biodegradable PCL-PEG-PCL [328].”
Method
Metadata
- Authors
- Tomlinson, R., Klee, M., Garrett, S., Heller, J., Duncan, R., & Brocchini, S.
- Venue
- Macromolecules
- Publisher
- American Chemical Society (ACS)
- Published
- 2001-12-18
- Volume
- 35
- Issue
- 2
- Pages
- 473-480
- ISSN
- 0024-9297 (ISSN-L)
- 1520-5835
- OpenAlex
- W2060571466
- Cited by
- 118
- References
- 0
- FWCI
- 1.50
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.